The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect ...

The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious ...

The Food and Drug Administration announced that Philips recalled the software following 109 reported injuries and two ...

Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...

Philips recalls software for mobile cardiac telemetry devices after patient injuries and deaths. Urgent medical device correction issued. Class I recall.

Another 109 people reported injuries after using the remote cardiac monitoring software, Modern Healthcare reported. Other pharmaceutical and tech news is on the FDA's drug approval system and a rapid ...

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...

While Philips' ePatch offers 14-day continuous monitoring for heart and blood pressure, enhancing the detection and diagnosis of AF, a common cardiac arrhythmia, the AI-driven Cardiologs analytics ...

Mayo Clinic and Philips are collaborating to investigate ways artificial intelligence can make cardiac MRI scans faster. Mayo Clinic will combine its proprietary AI technology with Philips ...

A complex cardiac MRI exam can take ... image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs ...